Rapporté par Dominique Valade (AP-HP, Lariboisière) d’après les communications : The Pharmacokinetic Properties of Pregabalin and Gabapentin: Differences and Similarities D. Wesche, H. Bockbrader Program No. 644-P250. Pregabalin - is it any better than Gabapentin ? S. Allen Program No. 598-P204. Model - Based Evaluation of the Cost - Effectiveness of Pregabalin versus Gabapentin in Patients with Painful Diabetic Polyneuropathy and Postherpetic Neuralgia: A Spanish Perspective J. Gonzalez-Escalada, M. Rodriguez, J. Rejas, M. Vera-Llonch,...

Rapporté par Dominique Valade (AP-HP, Lariboisière) d’après les communications : An open - label follow - on trial to assess the long - term safety and efficacy of oral Lacosamide (SPM 927) in subjects with diabetic neuropathy A. Shaibani, J. Simpson, B. Koch Program No. 193-P170. A multicenter, randomized, double - blind, placebo - controlled trial to assess the efficacy and safety of Lacosamide in subjects with painful distal diabetic neuropathy D. Ziegler, S. Bongardt, S. Thierfelder, B. Koch Program No. 1642-P145. 11^th World...

Rapporté par Dominique Valade (AP-HP, Lariboisière) d’après la communication : Comparison of venlafaxine and gabapentine in the treatment of neuropathic pain A. Yucel, S. Ozyalcin, G.-K. Talu, R. Disci Program No. 619-P225. 11^th World Congress on Pain - 21-26 août 2005 – Sydney, Australie

Rapporté par Dominique Valade (AP-HP, Lariboisière) d’après les communications : Adverse effects of antidepressants for pain patient K. Kishida, K. Yamanouchi, C. Saeki, Y. Kuriyama, M. Kitahara, A. Ohmura Program No. 615-P221. Effects of analgesic treatment with amitriptyline on dribing ability in patients with chronic neuropathic pain D.-S. Veldhuijzen, E.-R. Volkerts, A.-J. van Wijck, J.-C. Verster, C.-J. Kalkman, L. Kenemans, B. Olivier Program No. 611-P217. Use of Tricyclic Antidepressants in Older Patients with Painful Neuropathic...

Rapporté par Michel Lantéri-Minet (CHU de Nice) d’après les communications : Duloxetine in the treatment of diabetic peripheral neuropathic pain - results from three clinical trials J. Raskin, Y.-L. Pritchett, A.-S. Chappell, D.-N. D'Souza, S. Lyengar, C.-K. Wong, J.-F. Wernicke, D.-J. Goldstein Program No. 614-P220. Differential Effects of selective norepinephrine and serotonin reuptake blockers in preclinical pain modelsA.-K. Houghton, G.-M. Gourlay, R. Palin Program No. 587-P193. Lack of antinociceptive synergy between a selective...

Rapporté par Michel Lantéri-Minet (CHU de Nice) d’après les communications : Spinal cord stimulation versus conventional medical management: a randomised controlled study of patients with failed back surgery syndrome ( PROCESS study ) - study design & demographics K. Kumar Program No. 1751-P254 Automated Versus Manual Spinal Cord Stimulator Adjustment: A Sensitivity Analysis of Lifetime Cost Data From a Randomized, Controlled TrialA.-A. Khalessi, R.-S. Taylor, D. Brigham, R. North Program No. 1754-P257 A Prospective Study Comparing an Enhanced...

Rapporté par Michel Lantéri-Minet (CHU de Nice) d’après les communications : Motor cortex stimulation for refractory neuropathic pain: Four years outcome and predictors of efficacy C. Nuti, P. Mertens, R. Peyron, J. Brunon, L. Garcia-Larrea, B. Laurent, M. Sindou Program No. 1752-P255 Motor cortex stimulation in neuropathic pain. A PET study in favour of top - down mechanisms of action R. Peyron, P. Mertens, I. Faillenot, B. Laurent, M. Sindou, L. Garcia-Larrea Program No. 1755-P258. 11^th World Congress on Pain - 21-26 août 2005 –...

Rapporté par Michel Lantéri-Minet (CHU de Nice) d’après la communication : Representation of older patients in randomized controlled trials of adjuvant analgesics for neuropathic pain D. Lussier, A. Velly Program No. 513-P119 11^th World Congress on Pain - 21-26 août 2005 – Sydney, Australie

Rapporté par Michel Lantéri-Minet (CHU de Nice) d’après la communication : A Multicenter, Randomized, Double - Blind, Placebo - Controlled, Parallel Group Study to Evaluate the Efficacy and Tolerability of a 14 Day Treatment Course of GW493838 50mg Compared to Placebo in Subjects with Peripheral Neuropathic Pain (GlaxoSmithKline Study A1A20004) P.-D. Meisner, J.-M. Appleby, D.-E. Blum, R.-M. Dixon, A.-C. Nelsen, S.-N. Quessy, S. Shaikh, J.-D. White, P.-M. Williams Program No. 637-P243. 11^th World Congress on Pain - 21-26 août 2005 – Sydney,...

Rapporté par Michel Lantéri-Minet (CHU de Nice) d’après les communications : A multi - centre, double - blind, randomised, placebo - controlled trial of sativex, a cannabis based medicine (CBM), in the treatment of neuropathic pain T. Nurmikko, M. Serpell, B. Hoggart, P. Toomey, B. Morlion, D. Haines, N. Sarantis Program No. 660-P266. A randomised controlled trial of sativex, a cannabis based medicine (CBM), in central neuropathic pain due to multiple sclerosis, followed by an open - label extension C.-A. Young, D.-J. Rog, T.-J. Nurmikko, A....

Rapporté par Michel Lantéri-Minet (CHU de Nice) d’après la communication : Treatment of non - herpetic peripheral pain syndromes with lidocaine patch 5% M. Faust, U. Gosch, A. Roth-Isigkeit, M. Hueppe, J. Bogousslavsky, G. Wasner, R. Baron, T. Meier Program No. 918-P160. 11^th World Congress on Pain - 21-26 août 2005 – Sydney, Australie